Evidence map›Paper›PMID 35625234›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Phenotypic and Molecular Characterization of Carbapenem-Heteroresistant

Zain Baaity, Friederike D von Loewenich, Elisabeth Nagy, László Orosz, Katalin Burián, Ferenc Somogyvári, József Sóki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Clinical Significance ofMicroorganisms · 2026
    Article
  2. Article
  3. Article
  4. Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Zain BaaityInstitute of Medical Microbiology, Albert Szent-Györgyi Health Centre and School of Medicine, University of Szeged, H-6725 Szeged, Hungary.ORCID 0000-0001-6411-382X
Friederike D von LoewenichDepartment for Medical Microbiology and Hygiene, University of Mainz, D-55131 Mainz, Germany.ORCID 0000-0002-7887-3704
Elisabeth NagyInstitute of Medical Microbiology, Albert Szent-Györgyi Health Centre and School of Medicine, University of Szeged, H-6725 Szeged, Hungary.ORCID 0000-0001-6590-1879
László OroszInstitute of Medical Microbiology, Albert Szent-Györgyi Health Centre and School of Medicine, University of Szeged, H-6725 Szeged, Hungary.
Katalin BuriánInstitute of Medical Microbiology, Albert Szent-Györgyi Health Centre and School of Medicine, University of Szeged, H-6725 Szeged, Hungary.ORCID 0000-0003-1300-2374
Ferenc SomogyváriInstitute of Medical Microbiology, Albert Szent-Györgyi Health Centre and School of Medicine, University of Szeged, H-6725 Szeged, Hungary.ORCID 0000-0001-8409-892X
József SókiInstitute of Medical Microbiology, Albert Szent-Györgyi Health Centre and School of Medicine, University of Szeged, H-6725 Szeged, Hungary.ORCID 0000-0001-9230-8907
University of Szeged · HUJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Bacteroides fragiliscarbapenem resistanceGNAT acetyltransferase toxinheterogeneous resistanceimipenemtoxin-antitoxin pair

Identifiers

PMID35625234
PMCPMC9138018
OpenAlexW4225124594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.